|

NLY01 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Johns Hopkins University1

Indications

  • Multiple Sclerosis1

Baltimore, Maryland1 trial

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Johns Hopkins University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.